Olivia Driscoll

Olivia Driscoll, M.S. BioBusiness, currently holds the position of Business Development and Corporate Strategy Manager at United Therapeutics Corporation, where responsibilities include supporting the sourcing, evaluation, and execution of value-generating business transactions. Prior experience includes serving as a Senior Research and Analysis Healthcare Associate at S&P Global, as well as intern roles focused on strategic operations and healthcare research at Stella Diagnostics and other firms. Educational qualifications include a Master of Science in Biotechnology from Georgetown University and a Bachelor of Science in Molecular Toxicology from the University of California, Berkeley. Throughout a diverse career in healthcare and business analysis, Olivia has developed expertise in market trends, healthcare sector analysis, and corporate strategy.